Revelation Biosciences (REVB) Long-Term Debt Repayments (2022)
Revelation Biosciences' Long-Term Debt Repayments came in at $2.5 million for FY2022.
Powered by 
Analysis
Revelation Biosciences (REVB) Long-Term Debt Repayments (2022) Analysis & Trends
- Per Business Quant, earlier years put Long-Term Debt Repayments at $150,000 in FY2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,163.48 Bn | 1,132.06 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 631.16 Bn | 549.69 Bn | 17.26 Bn | 1.00 Mn |
| 3 | AbbVie | 502.63 Bn | 475.74 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 378.53 Bn | 332.91 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 302.83 Bn | 266.82 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 265.92 Bn | 239.60 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 240.87 Bn | 196.27 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.04 Bn | 168.24 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | - |
| 10 | Revelation Biosciences | 13.79 Mn | -35.23 Mn | - | - |
API Access
Revelation Biosciences Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();